255 related articles for article (PubMed ID: 11832089)
41. Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences.
Bedke J; Buse S; Pritsch M; Macher-Goeppinger S; Schirmacher P; Haferkamp A; Hohenfellner M
BJU Int; 2009 May; 103(10):1349-54. PubMed ID: 19076147
[TBL] [Abstract][Full Text] [Related]
42. [Important prognostic factors in surgically treated gastric cancer patients].
Hiratsuka M; Iwanaga T; Furukawa H; Yasuda T; Nakano H; Nakamori S; Ohigashi H; Kameyama M; Sasaki Y; Kabuto T
Gan To Kagaku Ryoho; 1995 Apr; 22(5):703-8. PubMed ID: 7717727
[TBL] [Abstract][Full Text] [Related]
43. Prognostic significance of macroscopic serosal invasion in advanced gastric cancer.
Yasuda K; Shiraishi N; Inomata M; Shiroshita H; Izumi K; Kitano S
Hepatogastroenterology; 2007; 54(79):2028-31. PubMed ID: 18251153
[TBL] [Abstract][Full Text] [Related]
44. Ratio of metastatic lymph nodes: impact on staging and survival of gastric cancer.
Persiani R; Rausei S; Biondi A; Boccia S; Cananzi F; D'Ugo D
Eur J Surg Oncol; 2008 May; 34(5):519-24. PubMed ID: 17624713
[TBL] [Abstract][Full Text] [Related]
45. The decision criterion of histological mixed type in "T1/T2" gastric carcinoma--comparison between TNM classification and Japanese Classification of Gastric Cancer.
Shimizu H; Ichikawa D; Komatsu S; Okamoto K; Shiozaki A; Fujiwara H; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Ochiai T; Kokuba Y; Kishimoto M; Yanagisawa A; Otsuji E
J Surg Oncol; 2012 Jun; 105(8):800-4. PubMed ID: 22189799
[TBL] [Abstract][Full Text] [Related]
46. Metastatic lymph node ratio as a prognostic factor in gastric cancer.
Rodríguez Santiago JM; Muñoz E; Martí M; Quintana S; Veloso E; Marco C
Eur J Surg Oncol; 2005 Feb; 31(1):59-66. PubMed ID: 15642427
[TBL] [Abstract][Full Text] [Related]
47. Prognostic significance of metastatic lymph node ratio in T3 gastric cancer.
Hyung WJ; Noh SH; Yoo CH; Huh JH; Shin DW; Lah KH; Lee JH; Choi SH; Min JS
World J Surg; 2002 Mar; 26(3):323-9. PubMed ID: 11865369
[TBL] [Abstract][Full Text] [Related]
48. Factors associated with pN3 stage tumors according to the TNM classification in advanced gastric cancer.
Kikuchi S; Katada N; Sakuramoto S; Koabayashi N; Shimao H; Sakakibara Y; Kakita A
Hepatogastroenterology; 2003; 50(53):1723-6. PubMed ID: 14571827
[TBL] [Abstract][Full Text] [Related]
49. Factors influencing outcome in gastric cancer involving muscularis and subserosal layer.
Fotia G; Marrelli D; De Stefano A; Pinto E; Roviello F
Eur J Surg Oncol; 2004 Nov; 30(9):930-4. PubMed ID: 15498636
[TBL] [Abstract][Full Text] [Related]
50. Prognostic and clinical evaluation of patients with T2 gastric cancer.
Komatsu S; Ichikawa D; Kurioka H; Kan K; Shioaki Y; Ueshima Y; Hamashima T; Lee CJ; Ikeda E; Ueda Y; Otsuji E; Oka T; Yamagishi H
Hepatogastroenterology; 2005; 52(63):965-8. PubMed ID: 15966242
[TBL] [Abstract][Full Text] [Related]
51. The significance of perineural invasion as a prognostic factor in patients with gastric carcinoma.
Duraker N; Sişman S; Can G
Surg Today; 2003; 33(2):95-100. PubMed ID: 12616368
[TBL] [Abstract][Full Text] [Related]
52. [Comparison of clinicopathologic parameters and prognosis of gastric carcinoma between different phases].
Cai SR; Chen CQ; Ma JP; Chen JH; Song W; He YL; Zhan WH
Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1264-8. PubMed ID: 19595182
[TBL] [Abstract][Full Text] [Related]
53. [Metastasis rates of lymph nodes and distribution in advanced gastric cancer and its clinical significance].
Nzengue JC; Zhan WH; Wang JP; Dong WG; Lan P; He YL; Chen ZX; Cai SR
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):506-9. PubMed ID: 17143796
[TBL] [Abstract][Full Text] [Related]
54. Lymph node metastasis in early gastric cancer: a clinicopathological analysis.
Wu CY; Chen JT; Chen GH; Yeh HZ
Hepatogastroenterology; 2002; 49(47):1465-8. PubMed ID: 12239968
[TBL] [Abstract][Full Text] [Related]
55. Macroscopic tumor size as a simple prognostic indicator in patients with gastric cancer.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Oro S; Tatebe S; Tsujitani S; Ikeguchi M
Am J Surg; 2006 Sep; 192(3):296-300. PubMed ID: 16920421
[TBL] [Abstract][Full Text] [Related]
56. [Surgical treatment and prognosis analysis for patients with gastric cancer infiltrating esophagus].
Han FH; Zhan WH; He YL; Li YM; Zheng ZQ; Peng JS; Cai SR; Ma JP
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):199-202. PubMed ID: 16167226
[TBL] [Abstract][Full Text] [Related]
57. Is tumor size a prognostic indicator for gastric carcinoma?
Yokota T; Ishiyama S; Saito T; Teshima S; Yamada Y; Iwamoto K; Takahashi M; Murata K; Yamauchi H
Anticancer Res; 2002; 22(6B):3673-7. PubMed ID: 12552975
[TBL] [Abstract][Full Text] [Related]
58. [Multi-variate analysis of prognostic factors in gastric cancer with Cox' proportional hazard model].
Nakajima T; Ota K; Ishihara S; Wakabayashi K; Nishi M
Gan To Kagaku Ryoho; 1994 Aug; 21(11):1768-74. PubMed ID: 8080294
[TBL] [Abstract][Full Text] [Related]
59. [Prognostic significance of tumor size in the survival of patients with advanced gastric carcinoma].
Díaz Plasencia JA; Yan-Quiroz EF; Burgos-Chávez OA; Santillán-Medina JP; Stewart-Vilela Guillén E; Rojas-Vergara AM
Rev Gastroenterol Peru; 2001; 21(1):21-9. PubMed ID: 12170283
[TBL] [Abstract][Full Text] [Related]
60. Validation of the new AJCC TNM staging system for gastric cancer in a large cohort of patients (n = 2,155): focus on the T category.
Marchet A; Mocellin S; Ambrosi A; Morgagni P; Vittimberga G; Roviello F; Marrelli D; de Manzoni G; Minicozzi A; Coniglio A; Tiberio G; Pacelli F; Rosa F; Nitti D
Eur J Surg Oncol; 2011 Sep; 37(9):779-85. PubMed ID: 21726975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
